Prediktory pozitivního léčebného výsledku u pa cientů s akutní cévní mozkovou příhodou podstupujících endovaskulární léčbu -výsledky z registru CERBERUS Abstract Background: Endovascular ther apy (EVT) with stent retrievers has been shown to be superior and safe (in the anterior circulation) in comparison to intravenous thrombolysis (IVT) alone or no specifi c ther apy. We compared clinical outcome between patients undergo ing EVT admitted directly to comprehensive stroke centers (CSCs) and patients transfer red from primary stroke centers (PSCs) to a CSC. Materials and methods: Demographics, risk factors, and medical history of all consecutive EVT-treated stroke patients in col laborat ing stroke centers were col lected. Patients were divided into three groups: treatment with IVT in a PSC before transfer to a CSC for EVT; treatment with IVT directly in a CSC with subsequent EVT in the same center; no treatment with IVT before EVT. Neurological status us ing the National Institutes of Health Stroke Scale (NIHSS) on admis sion and at day 7 and self-suffi ciency us ing the modified Rankin Scale (mRS) at day 90 were as ses sed. Favorable clinical outcome was defi ned as an mRS score of 0-2. Fol low-up computed tomography or magnetic resonance imag ing was done to determine symp tomatic intracerebral hemor rhage (SICH). Results: A total of 568 patients (313 males; mean age, 66.1 ± 13.2 years) were registered from January 2006 to the end of July 2015. Patients in all three groups did not diff er in baseline characteristics except for the time to the start of EVT. The average delay of EVT start in patients transfer red from PSC to CSC was 45 min. Subgroups did not diff er signifi cantly in SICH prevalence (over all prevalence 5.5%) and favorable clinical outcome (over all 46.7%). Conclusion: The benefi t of direct transfer to a CSC merits further investigation. The present study showed that both approaches to stroke patient transport organization in the Czech Republic are comparably effi cient and safe.
Objectives
Acute occlusion of large cerebral arteries is usual ly as sociated with severe neurologic defi cit and low chance for early recanalization with intravenous thrombolysis (IVT) [1] . In 2015, endovascular ther apy (EVT) with stent retrievers has been shown to be superior and safe (in the anterior circulation) in comparison to IVT alone or no specifi c therapy [2] [3] [4] [5] [6] [7] [8] [9] . Hence, this method should now be considered for all patients with acute ischemic stroke with occlusion of large cerebral ves sels (if the tim ing is favorable). EVT requires changes to the protocol for acute management of stroke, pre-hospital care, com munication and treatment organization with primary stroke centers (PSCs) and comprehensive stroke centers (CSCs). The goal is to determine optimal management for stroke patients with largeves sel occlusion.
Stroke care in the Czech Republic has changed considerably dur ing the last 20 years. Since 1998, IVT treatment has started to be used routinely in selected neurology departments for acute ischemic stroke. Several hospitals built specialized stroke units provid ing comprehensive care for stroke patients from the very begin ning, whereas other hospitals col laborated with (usual ly internal) intensive care units (ICUs). EVT has been used in the Czech Republic since 2005, mostly in university hospitals, rarely in local hospitals.
In 2010, a national two-level network of acute stroke care was created. Initial ly, this was a network of 32 PSCs provid ing acute stroke care (multi-modal dia gnostics, care in a stroke unit, IVT administration, early rehabilitation, primary/ secondary preventive care and treatment of com mon complications) and col laborat ing with the nearest CSC. CSCs also provide EVT, complex neurosurgical care and consultations to PSCs and local neurological departments for preventive and fol low-up care with regard to cerebrovascular dis ease (second level, 13 CSCs).
Each PSC has a target population (≈250,000-500,000 inhabitants) to care for based on geography and population density. Stroke care is provided by a neurologist and each PSC must have a Stroke Unit. The admis sion work-up does not diff er between PSCs and CSCs, and always comprises neurologic examination, basic laboratory tests, computed tomography (CT) or magnetic resonance imag ing (MRI) and, in all patients suitable for IVT or EVT, additional computed tomography angiography (CTA) or magnetic resonance angiography (MRA). The typical work-up time in the submitted patient population (January 2006 until the end of July 2015) is consistent with the doorto-needle time (DNT) for IVT and is ≈55 min. There is usual ly one CSC in each region/ territorial unit of the Czech Republic (14 regions, includ ing the capital city Prague) that collaborates with PSCs in the same area (on a geographical basis) and covers a population of 800,000-1,200,000 inhabitants. The distances and travel times between PSCs and CSCs vary in dif ferent parts of the country, usual ly from 10 to 90 min [10, 11] .
Time-to-recanalization is an es sential parameter. However, how to pre-select patients suitable for EVT in pre-hospital care (i.e., whether to transfer to a PSC with early IVT and secondary transport to a CSC for EVT, or direct transfer of patients with severe neurological impairment to a CSC for IVT and EVT) is not known.
We compared the clinical outcome between patients: 1. indicated for EVT after IVT failure and admitted directly to a CSC and patients transfer red from a PSC to CSC after IVT; 2. treated us ing EVT after failed IVT treatment and 3. patients contraindicated to IVT treated with EVT only. Also, we wished to identify predictors of symp tomatic intracerebral hemor rhage (SICH) and good
Souhrn
Úvod: Endovaskulární terapie (EVT) s použitím stent-retrieverů (v přední cirkulaci) již prokázala svou superioritu a bezpečnost ve srovnání se samotnou intravenózní trombolýzou (IVT) nebo žádnou specifi ckou terapií. Srovnali jsme klinický výsledek pa cientů s ischemickou cévní mozkovou příhodou (iCMP) podstupujících EVT přijatých direktně do komplexních cerebrovaskulárních center (KCC) s pa cienty transferovanými sekundárně z lokálních iktových center (IC) do KCC. Metodika a pa cienti: Byly zaznamenány demografi cké údaje, rizikové faktory a zdravotní anamnéza všech konsekutivních pacientů léčených EVT ve spolupracujících iktových centrech KCC/IC. Pa cienti byli rozděleni do tří skupin: léčba IVT v IC před transferem k EVT do KCC; léčba IVT přímo v KCC s navazující EVT v tomtéž centru; žádná IVT před EVT. Neurologický stav při přijetí a 7. den byl hodnocen za využití National Institutes of Health Stroke Scale (NIHSS). Soběstačnost pa cientů 90. den byla hodnocena pomocí modifi kované Rankinovy škály (mRS). Jako dobrý klinický výsledek bylo označeno skóre mRS 0-2. Kontrolní vyšetření výpočetní tomografií nebo magnetickou rezonancí byla provedena k vyloučení symp tomatického intracerebrálního krvácení (SICH 
Patients, inclusion criteria and organization of EVT treatment
In the Czech Republic, all acute-stroke patients found to be within the time window for IVT and without known contraindication for IVT must be transfer red to the nearest stroke center (PSC or CSC) for dia gnostics and IVT.
The EVT was indicated in the stroke centers participat ing in the CERBERUS under five conditions: 1. occlusion of large vessels (middle cerebral artery (MCA), internal carotid artery (ICA) -occlusion of the cervical segment with/ without MCA occlusion or T-type occlusion, basilar artery (BA) diagnosed with CTA or MRA); 2. procedure start within 6-8 hours (an 8-hour time window was applied in particular CSCs based upon approval of the local ethics com mittee) after stroke onset with specifi c exceptions (e. g., posterior circulation stroke due to BA occlusion); 3. IVT failure (no neurological improvement after IVT start till the start of EVT or dur ing transfer) or contraindication to IVT; 4. neurological defi cit upon hospital admis sion of ≥ 8 points (us ing the National Institutes of Health Stroke Scale; NIHSS) or fl uctuat ing neurological defi cit; 5. self-suffi ciency before cur rent stroke (0-2 points in the modified Rankin scale; mRS).
All CT/ MRI scans were viewed local ly. No standardized imaging-based patient selection system, such as Alberta Stroke Program Early CT (ASPECT) score, was used routinely. Endovascular team was cal led immediately after major artery occlusion dia gnosis and when no contraindication for EVT existed. PSC stroke physician was required to contact a CSC im mediately after imaging. Transfer from the PSC to the CSC was performed by regional Emergency Medical Service (EMS) at the highest priority level. CT or MRI scans were transfer red us ing a national picture archiv ing and com munication system (PACS) to the CSC; however, this could not delay the transfer organization. Imag ing was not routinely repeated in the CSC after transfer unless neurological deterioration (> 4 NIHSS points) occur red.
All stroke centers that were a part of the CERBERUS col lected prospective data on all consecutive EVT-treated stroke patients to the registry. Demographics (age, sex) as well as information on risk factors and medical history (blood pres sure, blood glucose, blood cholesterol, smok ing status, alcohol consumption, treatment with antithrombotic drugs/ statins, body mass index (BMI), pre-event transient ischemic attack (TIA) or stroke, atrial fi bril lation) were col lected at baseline. The NIHSS was used to as sess stroke severity and the mRS to determine self-suffi ciency.
Patients were divided into three groups: treatment with IVT in a PSC before transfer to a CSC for EVT (group 1); treatment with IVT directly in a CSC fol lowed by EVT in the same center (group 2); no treatment with IVT before EVT due to a contraindication to IVT or outside the time window (group 3).
The CERBERUS contains data on patients with stroke in the anterior and posterior circulation. However, to compare EVT efficacy (recanalization rate, 90-day clinical outcome) and safety (occur rence of SICH and malignant brain edema) six subgroups based on occlusion site were created: 1. isolated MCA; 2. isolated ICA; 3. ICA + MCA (with patent anterior cerebral artery); 4. T-type ICA; 5. vertebral artery (VA) occlusion with contralateral chronic occlusion or distal embolization to the posterior circulation (VA+); 6. BA occlusion.
Treatment methods
Five methods were used for EVT of occluded cerebral arteries in the participat ing stroke centers: 1. mechanical thrombectomy with stent retrievers; 2. percutaneous trans luminal angioplasty with/ without stenting; 3. endovascular sonolysis; 4. intra-arterial thrombolysis; 5. combination of methods. The method was selected by an interventional radiologist.
All logistic data (onset-to-needle time and DNT for IVT; onset-to-groin puncture time, door-to-groin puncture time, procedure time and onset-to-recanalization time for EVT) were as ses sed in all groups (if applicable).
Recanalization and outcome parameters
Recanalization rate was as ses sed local ly us ing the Thrombolysis in Cerebral Infarction (TICI) score. Succes sful recanalization was defined as a score of 2b-3. Neurological status in the NIHSS on day 7 and day 90 and self-suf ficiency us ing the mRS on day 90 were as ses sed in all patients. Favorable clinical outcome was defined as an mRS score of 0-2. Fol low-up CT or MRI was performed in all patients ≤ 24 hours from the stroke onset (and as neces sary at any time in case of neurological worsening) to determine SICH. SICH was determined as ICH on the fol low-up CT or MRI in combination with deterioration in NIHSS of ≥ 4 points. Malignant brain edema was as ses sed clinical ly as deterioration in NIHSS of ≥ 4 points with midline shift on the follow-up CT or MRI.
Statistical analyses
The normality of data distribution was tested us ing the Shapiro-Wilk test. Categorical variables are reported as frequencies and percentages. Data with normal distribution are reported as a mean ± standard deviation (SD). Parameters not fitt ing the normal distribution are presented as a median and interquartile range (IQR). Categorical variables in the two arms were compared us ing Fisher's exact test. Continuous variables were compared us ing the Man n-Whitney U-test. Univariate and multiple logistic regres sion analyses with calculation of non--adjusted and adjusted odds ratios (ORs) were used to determine pos sible predictors of succes sful arterial recanalization, ma lignant brain edema, and favorable 90-day clinical outcome, respectively. The fol low ing variables were included in the analyses: age, sex, history of arterial hypertension, diabetes mellitus, hyperlipidemia, BMI, smoking, alcohol proLékaře.cz | 11.3.2020 abuse, atrial fi bril lation, previous TIA, previous stroke, previous use of antithrombotic agents, statin ther apy started before or within 24 h after stroke onset, baseline NIHSS, baseline systolic blood pres sure, baseline diastolic blood pres sure, baseline glucose level, baseline cholesterol level, IVT administration, location of arterial occlusion, procedure time and onset-to-recanalization time. All tests The three groups of patients did not differ in baseline characteristics except for the time to start of EVT. Time from a CSC admis sion to the start of EVT (door-to-groin puncture time) was signifi cantly shorter in patients dia gnosed and treated primarily with IVT in a PSC, whereas the dia gnosis was made already in the PSC. On the contrary, time from stroke onset to the start of the EVT procedure was signifi cantly shorter in patients treated with IVT fol lowed by EVT in the same CSC. Procedure length did not differ signifi cantly between groups regardless of previous IVT. The time-to-recanalization also did not diff er signifi cantly between the IVT (groups 1 and 2) and non-IVT (group 3) patients but was significantly shorter in patients treated with IVT in a CSC (group 1) compared to those treated with IVT in a PSC (group 2). Onset-to-hospital ar rival time proLékaře.cz | 11.3.2020
Higher baseline NIHSS score and blood glucose level, right-hemisphere stroke, ICA-MCA, and T-type ICA occlusion were independent negative predictors of malignant brain edema in patients who had a stroke in the anterior circulation (Tab. 5). No predictor of malignant brain edema was identified for patients who had a stroke in the posterior circulation.
Older age, history of arterial hypertension and diabetes mel litus, baseline NIHSS, systolic blood pres sure, blood glucose level, BMI and procedure duration were negative predictors of favorable clinical outcome at 90 days. Isolated ICA occlusion, history of hyperlipidemia and statin treatment were positive predictors of favorable 90-day clinical outcome (Tab. 6). Of these parameters, only older age, baseline NIHSS, baseline blood glucose level and procedure duration were independent negative predictors of good clinical outcome. A history of statin treatment was an independent positive predictor of good clinical outcome (Tab. 7).
Discus sion
This is the fi rst study compar ing two systems of organization of stroke care. Patients treated with EVT after IVT failure admitted directly to a CSC had signifi cantly shorter onset-to-start of EVT time and onset-to-recanalization time than patients treated with IVT in a PSC and transfer red subsequently to a CSC. However, this dif ference could have been even greater should the endovascular team be inhouse in a "24/ 7" regimen. At present, CSC endovascular teams in the Czech Republic are contacted mostly by telephone [10, 11] . When an occlusion of a major artery is diagnosed, CSC members are telephoned treated with intra-arterial thrombolysis alone or in combination with another method. Favorable clinical outcome was achieved in 55.4% of patients who had succes sful recanalization (TICI 2b-3) vs. 22.1% of patients with the TICI score of 0-2a (p < 0.0001).
The only independent negative predictor of succes sful recanalization in all patients was the duration of the procedure (adjusted OR 0.985; 95% confidence interval (CI): 0.976-0.993; p = 0.0002) and, in patients with occlusion in the anterior circulation, also IVT DNT (adjusted OR 0.986; 95% CI 0.974-0.998, p = 0.027). There was no significant difference in the likelihood of achiev ing recanalization between subgroups with regard to occlusion site (Tab. 4).
Higher blood glucose level at baseline and longer DNT were identified as independent predictors of the risk of SICH in all patients (adjusted OR 1.016; 95% CI 1.002-1.029; p = 0.024; and adjusted OR 1.145; 95% CI 1.018-1.288; p = 0.024, respectively).
(68 vs. 75 min, respectively) and DNT did not diff er signifi cantly between PSCs and CSCs. The average delay of EVT start in transfer red patients was 45 min and varied depend ing on the availability of EMS transfer, duration of transfer, and work-up time in a PSC. Unfortunately, the time of transfer and time spent in a PSC before transfer was not measured (Tab. 1, 2).
Patients were treated using: 1. mechanical thrombectomy with stent retrievers (254 subjects); 2. percutaneous transluminal angioplasty with/ without stent ing (157 subjects); 3. endovascular sonolysis (3 subjects); 4. intra-arterial thrombolysis (24 subjects) or 5. combination of methods (130 subjects).
Over all prevalence of SICH was 5.5%. On day 90, 46.7% of patients achieved favorable clinical outcome (mRS 0-2) and further 8. CI -confi dence interval; ICA -internal carotid artery; MCA -middle cerebral artery; NIHSSNational Institutes of Health Stroke Scale; OR -odds ratio strokes and better col lateral circulation in comparison to the MCA; 2. the brainstem is nourished with smal l-ended arteries [13] .
Higher baseline blood glucose levels and longer DNT were identified as independent prevalence of ICH was 17.2% in patients with stroke in the anterior circulation and 5.1% only in patients with a stroke in the posterior circulation. These findings could be due to: 1. lower lesion volume in infratentorial first; subsequently, it takes (on average) additional 40 min to start the procedure. This delay is eliminated in patients transferred from PSCs as the endovascular team arrives dur ing the patient's transfer to a CSC. Clinical outcome was not signifi cantly different between these two groups and a trend towards better results was observed in patients treated directly in a CSC only. Further shorten ing of the door-to-puncture time in a CSC seems to be es sential and can show statistical signifi cance but is limited mainly by human and economic resources. Nevertheles s, the cur rent two-level system in the Czech Republic shows that both ways, if well organized, are ful ly comparable, show ing similar results in terms of reaching favorable clinical outcomes. Thus, the most suitable strategy (primary transport to a CSC or primary transport to a PSC with secondary transport to a CSC) should be chosen for a particular region depend ing on local conditions and ensur ing that IVT does not delay EVT and vice versa.
Succes sful recanalization (TICI 2b-3) in diff erent arterial ter ritories was achieved in 54.5-78.6% of subjects in the CERBERUS, with the lowest prevalence be ing in VA+ occlusions and the highest be ing in MCA occlusions. Prevalence of reperfusion (TICI 2b-3) in the anterior circulation was achieved in 74% of patients, similarly to the results of randomized trials (72.4-88.0% [2] [3] [4] [5] [6] ) and almost identical ly to a similar retrospective study us ing data from a Belgian registry (73%). Prevalence of recanalization achieved in strokes in the posterior circulation in the CERBERUS was lower than that achieved in the Belgian registry (71 vs. 100%) [12] .
Patients who underwent EVT after IVT failure and patients contraindicated to IVT treated with EVT only did not dif fer significantly in terms of clinical outcome (mRS 0-2 in 46.3 vs. 47.0%) and SICH (6.5 vs. 4.0%). These percentages are similar to comparable groups in randomized clinical trials [2] [3] [4] [5] [6] .
Prevalence of SICH was not signifi cantly higher in patients treated directly in a CSC and varied in diff erent regions from 0% (VA+) to 8.1% (ICA). In our study, SICH was more prevalent in the anterior circulation (6.2%) than in the posterior circulation (1.1%). These results diff ered from those obtained in the Belgian study (3 vs. 13%) [12] . Nevertheles s, our find ing is similar to that reported by Dornak et al., who found that in patients treated with IVT alone (not with EVT), CERBERUS centers. Therefore, our results are almost identical with studies that did not use perfusion methods [3, 12] . The EXTEND-IA trial, in which CTA/ CTP was used for patient selection, showed higher prevalence of favorable clinical outcome (71%) [2] . Our study had several main limitations. First, there was no control group and thus the eff ect of EVT vs. IVT alone could not be as ses sed. Second, since the participating centers used individual EVT protocols, selection bias can not be excluded. Third, unified imaging-based selection system was not used and no blinded evaluation of recanalization grade was performed. Fourth, there was no control CT scan performed immediately before EVT in patients transferred from a PSC to a CSC. Fifth, all data were col lected prospectively but data on some predictive variables could have been mis sed. Sixth, no central evaluation of recanalization and outcome rates was performed. Final ly, various methods or their combination (mostly percutaneous transluminal angioplasty with/ without stenting) were used dur ing the early years of EVT in the found ing CERBERUS center (Ostrava), though results were fully comparable with those from clinical trials us ing stent retrievers exclusively [20] .
Our study also had strengths. It was a multicenter as ses sment of clinical exper ience with EVT that elicited similar results to those from large randomized clinical trials. Hence, EVT can be considered to be ef ficient and safe in daily routine use in selected patients. Only patients with IVT failure and patients contraindicated to IVT were included. Thus, inclusion of patients with a favorable response to IVT (that could have infl uenced the results) was minimized.
Conclusion
We showed that EVT is eff ective and safe. It can be used routinely in selected patients with acute stroke and large-ves sel occlusion and especial ly in those with IVT failure or a contraindication to IVT. The benefi t of direct transfer to a CSC merits further investigation. The trend for better clinical outcome observed in patients treated directly in a CSC suggests that treatment should be in specialised centers with availability of all treatment options. However, this strategy could be region-specifi c depend ing on the density of PSCs and CSCs and the distances between them. Our study showed that in the Czech Republic both approaches are comparably eff ective and safe.
predictors of the risk of SICH in all patients in our study. In the study performed by Nogueira et al., independent predictors of hemor rhagic infarction included diabetes mel litus, pre-procedure IVT, MERCI thrombectomy and longer time-to-groin puncture [14] . Higher baseline NIHSS score and blood glucose level, right hemisphere stroke, ICA-MCA and T-type ICA occlusion were identified as independent negative predictors of malignant brain edema in our anterior circulation stroke patients. In comparison, concur rent involvement of the anterior cerebral artery, i.e. T-type ICA occlusion, was the only predictor of mortality in severe MCA stroke in the study by Walcott et al. [15] . No predictor of malignant brain edema was identified for posterior circulation stroke patients in our cohort.
In our study, older age, baseline NIHSS, baseline blood glucose level, and EVT duration were identified as independent negative predictors; a history of statin treatment was identified as an independent positive predictor of favorable clinical outcome. Ozdemir et al. found older age, blood glucose level, a higher Alberta Stroke Program Early CT (ASPECT) score, and longer onset-to-recanalization time to be negative predictors of favorable clinical outcome in anterior-circulation strokes [16] . These findings are consistent with our previous study in posterior-circulation strokes due to BA occlusion; higher NIHSS at the time of treatment, longer time to treatment and arterial hypertension were identified as independent negative predictors of favorable clinical outcome [17] . Likewise, the ASPECT score [18] , older age, stroke severity and a history of diabetes mel litus were identified as negative predictors of good clinical outcome in posterior-circulation strokes [19] .
Favorable clinical outcome (mRS 0-2) was identified in 33.3 (65.0%) of patients; the lowest proportion of patients with a positive outcome was observed in VA+ occlusions and the highest in isolated ICA siphon occlusions. In the CERBERUS, favorable clinical outcome in anterior-circulation strokes was achieved in 47.7% of patients compared to the results of randomized trials: 32% in MR CLEAN [3] , 44% in REVASCAT [4] , 53% in ESCAPE [5] and 60% in SWIFT PRIME [6] . Only patients with occlusions in large ves sels were included but selection based on computed tomography perfusion (CTP) was not used routinely in the
